�鶹ӰԺ

Endpoints News—OnKure Therapeutics has lined up $60 million in a new private funding round, adding to the CU �鶹ӰԺ spinout’s bank account as it works through a Phase II trial. The startup is attempting to create an inhibitor of histone deacetylases, or HDACs, which are DNA-manipulating enzymes that alter how genes get expressed.

Chemical Engineering—The partnership with New Iridium focuses on CO2 conversion via photocatalysis, the startup’s expertise, which is an innovative solution based on the use of light sources (for example, LEDs) and CO2 from industrial emissions in combination with low-cost raw materials.

Scientists from CU �鶹ӰԺ and the National Institute of Standards and Technology (NIST) made an important leap forward in the quest to diagnose disease using exhaled breath, reporting that a new laser-based breathalyzer—born of Nobel Prize-winning technology from CU—powered by artificial intelligence (AI) can detect COVID-19 in real-time with excellent accuracy.

Say “hello” to the robots of the future: They’re soft and flexible enough to bounce off walls or squeeze into tight spaces. And when you’re done with them, you can toss these machines into a compost bin to decompose.

Interesting Engineering—The primary goal of soft robotics is to achieve smooth and complex movement by mimicking the locomotion of soft bodies found in the environment. Researchers at CU �鶹ӰԺ and CU �鶹ӰԺ startup Artimus Robotics are leading innovation with a new type of "artificial muscle" to enable life-like movements.

What if improving one’s athletic performance through supplements was simpler and more affordable? What if, instead of producing emissions, airplanes could take carbon out of the air? These ideas and more are realities in the making, thanks to many aspiring entrepreneurs who pitched their products at the 16th annual New Venture Challenge (NVC) finals.